Despite smoking’s well-known role in causing lung cancer, a significant number of patients who develop lung tumors have never smoked. While scientists are still working to understand what spurs cancer in so-called ‘never-smokers,’ a study suggests that 78% to 92% of lung cancers in patients who have never smoked can be treated with precision drugs already approved by the Food and Drug Administration to target specific mutations in a patient’s tumor.
Click here for original story, Most cases of never-smokers’ lung cancer treatable with mutation-targeting drugs
Source: ScienceDaily